首页> 外文期刊>Medical decision making: An international journal of the Society for Medical Decision Making >Problems with interval estimates of the incremental cost-effectiveness ratio (see comments)
【24h】

Problems with interval estimates of the incremental cost-effectiveness ratio (see comments)

机译:增量成本效益比的区间估计存在问题(请参阅评论)

获取原文
获取原文并翻译 | 示例
       

摘要

The defining feature of a confidence interval is that it has a fixed minimum probability of covering the true value of the parameter being estimated, whatever the value of the parameter. The authors demonstrate by simulation that some recently proposed methods for interval estimation of the incremental cost-effectiveness ratio (ICER) either do not satisfy this definition or have other problems that limit their usefulness in applications. The problems are most prominent when the ICER is large and the true effectiveness difference is small relative to its standard error. A modification of the percentile bootstrap confidence interval that involves a reordering of the sample space provides a partial solution of the problem.
机译:置信区间的定义特征是,无论参数的值如何,它都有固定的最小概率覆盖估计的参数的真实值。作者通过仿真证明,最近提出的一些增量成本效益比(ICER)区间估计方法要么不满足该定义,要么存在其他问题,限制了它们在应用中的实用性。当ICER较大且相对于其标准误差而言,实际有效性差异较小时,问题最为突出。对百分位数自举置信区间的修改涉及对样本空间的重新排序,从而提供了部分解决方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号